Barclays’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $0 | Hold |
|
|||||
|
2018
Q4 | $0 | Hold |
|
|||||
|
2018
Q3 | $0 | Hold |
|
|||||
|
2018
Q2 | $0 | Sell |
|
|||||
|
2018
Q1 | $0 | Sell |
|
|||||
|
2017
Q4 | $121K | Buy |
|
|||||
|
2017
Q3 | $8K | Sell |
|
|||||
|
2017
Q2 | $222K | Buy |
|
|||||
|
2017
Q1 | $432K | Buy |
|
|||||
|
2016
Q4 | $308K | Sell |
|
|||||
|
2016
Q3 | $966K | Sell |
|
|||||
|
2016
Q2 | $1.25M | Sell |
|
|||||
|
2016
Q1 | $1.18M | Buy |
|
|||||
|
2015
Q4 | $254K | Buy |
|
|||||
|
2015
Q3 | $146K | Buy |
|
|||||
|
2015
Q2 | $9K | Sell |
|
|||||
|
2015
Q1 | $48K | Buy |
|
|||||
|
2014
Q4 | $30K | Sell |
|
|||||
|
2014
Q3 | $52K | Sell |
|
|||||
|
2014
Q2 | $165K | Buy |
|
|||||
|
2014
Q1 | $169K | Buy |
|
|||||
|
2013
Q4 | $4K | Sell |
|
|||||
|
2013
Q3 | $4K | Buy |
|